Abstract
Background. Multiple factors have been previously described which could influence adherence to HAART. Our objective is to determine the fundamental factors which influence adherence to highly active antiretroviral therapy in our population. Methods. A cross-sectional study was made selecting 143 outpatients attending our hospital HIV unit. 22 factors were recorded which could influence adherence to treatment (covering individual factors, the illness itself, the therapeutic regimen and the medical team). Adherence was estimated by the combination of two methods (self-report and pharmacy data); statistical analysis was performed using univariate and multivariate methods. Results. 96 patients (67.13%) had good adherence and 47 (32.87%) did not. Only 3 of the 22 factors studied were significant and independent factors related with adherence: employment, housing situation and degree of treatment acceptance. Conclusions. we have found some differences regarding HAART adherence in our population compared with previous studies. Psychosocial and behavioral factors were the principal ones. We must try to detect patients at high risk of nonadherence in order to take therapeutic decisions properly, try to reinforce adherence and modify the factors associated with poor adherence.
Keywords: Highly active antiretroviral therapy, patient compliance, HIV
Current HIV Research
Title: Factors Influencing Adherence to Highly Active Antiretroviral Therapy in Spain
Volume: 4 Issue: 2
Author(s): Leticia Moralejo, Sandra Ines, Miguel Marcos, Aurelio Fuertes and Guillermo Luna
Affiliation:
Keywords: Highly active antiretroviral therapy, patient compliance, HIV
Abstract: Background. Multiple factors have been previously described which could influence adherence to HAART. Our objective is to determine the fundamental factors which influence adherence to highly active antiretroviral therapy in our population. Methods. A cross-sectional study was made selecting 143 outpatients attending our hospital HIV unit. 22 factors were recorded which could influence adherence to treatment (covering individual factors, the illness itself, the therapeutic regimen and the medical team). Adherence was estimated by the combination of two methods (self-report and pharmacy data); statistical analysis was performed using univariate and multivariate methods. Results. 96 patients (67.13%) had good adherence and 47 (32.87%) did not. Only 3 of the 22 factors studied were significant and independent factors related with adherence: employment, housing situation and degree of treatment acceptance. Conclusions. we have found some differences regarding HAART adherence in our population compared with previous studies. Psychosocial and behavioral factors were the principal ones. We must try to detect patients at high risk of nonadherence in order to take therapeutic decisions properly, try to reinforce adherence and modify the factors associated with poor adherence.
Export Options
About this article
Cite this article as:
Moralejo Leticia, Ines Sandra, Marcos Miguel, Fuertes Aurelio and Luna Guillermo, Factors Influencing Adherence to Highly Active Antiretroviral Therapy in Spain, Current HIV Research 2006; 4 (2) . https://dx.doi.org/10.2174/157016206776055075
DOI https://dx.doi.org/10.2174/157016206776055075 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction
Current Drug Abuse Reviews Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Prognostic Significance of Homocysteine Levels in Acute Ischemic Stroke: A Prospective Cohort Study
Current Neurovascular Research Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Current Medicinal Chemistry Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
Current Pharmaceutical Design Cross Talk Among Leukocytes, Platelets, and Endothelial Cells and its Relevance to Atherosclerosis and Coronary Heart Disease
Current Nutrition & Food Science Editorial (Thematic Issue:Neuroscience of Exercise: Focus on Cognitive and Brain Functioning)
CNS & Neurological Disorders - Drug Targets Electrochemistry of Alzheimer Disease Amyloid Beta Peptides
Current Medicinal Chemistry Preventive Effect of Soybean on Brain Aging and Amyloid-β Accumulation: Comprehensive Analysis of Brain Gene Expression
Recent Patents on Food, Nutrition & Agriculture Prediction of Cell Wall Lytic Enzymes Using Chous Amphiphilic Pseudo Amino Acid Composition
Protein & Peptide Letters Potential Therapeutics for Vascular Cognitive Impairment and Dementia
Current Neuropharmacology Patent Selections
Recent Patents on Anti-Infective Drug Discovery Interaction Models of a Series of Oxadiazole-Substituted α-Isopropoxy Phenylpropanoic Acids Against PPARα and PPARγ: Molecular Modeling and Comparative Molecular Similarity Indices Analysis Studies
Protein & Peptide Letters Effects of Anticancer Drugs in Reproductive Parameters of Juvenile Male Animals and Role of Protective Agents
Anti-Cancer Agents in Medicinal Chemistry Role of Retinoids, Rexinoids and Thyroid Hormone in the Expression of Cytochrome P450 Enzymes
Current Drug Metabolism Inhibition of Monoamine Neurotransmitter Transporters andCentral Nervous System Stimulation Induced by Synthetic Local Anesthetics and Cocaine: A Comparative Review
Current Medicinal Chemistry - Central Nervous System Agents Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases
Current Pharmaceutical Design Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective
Current Pharmaceutical Biotechnology Growth Factor Therapy in Atherosclerotic Disease-Friend or Foe
Current Pharmaceutical Design Glycosomal Targets for Anti-Trypanosomatid Drug Discovery
Current Medicinal Chemistry